Virtual Only

REGISTRATION IS FREE

Join Dr Zoe Hewitt as she shares the story of her career journey, from completing her PhD to becoming Co-Founder and CEO of Regenerative Cell Therapy Consulting (Regen CTC) Limited.

In this seminar, Zoe will reflect on the key stages of her career, the experiences and decisions that shaped her path, and what inspired her to take the step into entrepreneurship and build her own consultancy.

Speaker 

Dr Zoe Hewitt
Co-Founder and CEO at Regenerative Cell Therapy Consulting (Regen CTC) Limited.

Zoe has a background in Pluripotent Stem Cells, which started in 2001 when she obtained her PhD from the Roslin Institute/ University of Edinburgh. After completing her studies, she worked with a team developing differentiation protocols for hepatocytes, before moving to the University of Sheffield in 2006, where she established and managed a clean room facility, which was responsible for deriving the UKs first clinically available human Embryonic Stem Cells (MasterShef lines 1 to 14). Within this facility, Zoe and her team were responsible for delivering the starting master cell banks (Shef1) for the London Project to Cure Blindness. This resulted in the first successful UK clinical trial of an hPSC-derived retinal pigment epithelium (RPE) cell replacement therapy.

In 2015, Zoe moved away from active research becoming a Project Manager for the UK Regenerative Medicine Platform (UKRMP), firstly for the Pluripotent Stem Cell Platform (PSCP) winning the UKRMP Special Merit Award in 2017 and then for the Pluripotent Stem Cell and Engineered Cell (PSEC) Hub. The goal of the UKRMP Hubs was to advance regenerative medicine therapies by delivering innovative approaches to the rate-limiting steps of hPSC-based cell replacement therapies to enable clinical delivery and commercial development.

Zoe co-founded Regenerative Cell Therapy Consulting limited in May 2022, where she now uses her considerable expertise to assist innovative research to translate from laboratory research, through to commercial development and investment.

The joining link will be sent to you following registration.